Literature DB >> 10215832

Transhiatal approach to total gastrectomy for adenocarcinoma of the gastric cardia.

J Wayman1, S M Dresner, S A Raimes, S M Griffin.   

Abstract

BACKGROUND: A thoracoabdominal approach has traditionally been described for the resection of tumours of the gastric cardia. The aim of this study was to evaluate a transhiatal approach for resection of cancers of the gastric cardia.
METHODS: Twenty consecutive patients undergoing transhiatal gastro-oesophagectomy for cancer of the gastric cardia were studied. Data were collected prospectively with regard to operating time, operative blood loss, intensive care unit (ICU) stay, analgesia use, duration of hospital stay, and pathological details of resection margin clearance and lymph node yield. Results were compared with those of the 20 preceding patients for whom the same prospective information had been recorded following resection via the standard thoracoabdominal approach.
RESULTS: The transhiatal approach required a shorter operating time (median 190 (range 105-255) versus 280 (225-330) min; P = 0.004). It resulted in less blood loss (median 405 (180-2000) versus 1000 (420-3200) ml; P = 0.03) and fewer days in the ICU (median 0 (0-31) versus 2 (1-8) days; P = 0.005) despite being performed in an older patient population (median 71 (43-78) versus 63 (59-70) years; P = 0.016). There was no difference in either the lymph node harvest or length or involvement of upper resection margins.
CONCLUSION: The transhiatal approach to the resection of tumours at the gastric cardia is a valid and safe alternative to the standard thoracoabdominal technique. This technique avoids thoracotomy and its associated morbidity and is accompanied by reduced blood loss, decreased operating time and a shorter ICU stay.

Entities:  

Mesh:

Year:  1999        PMID: 10215832     DOI: 10.1046/j.1365-2168.1999.01043.x

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  10 in total

1.  Should we continue oesophageal surgery in a district general hospital? A review of 200 consecutive cases.

Authors:  T C B Dehn; Iain Paterson; David Hunter; David Rae
Journal:  Ann R Coll Surg Engl       Date:  2002-07       Impact factor: 1.891

2.  Esophageal extension encountered during transhiatal resection of gastric or gastroesophageal tumors: attaining a negative margin.

Authors:  Diego Avella; Luis Garcia; Brett Hartman; Eric Kimchi; Kevin Staveley-O'Carroll
Journal:  J Gastrointest Surg       Date:  2008-08-02       Impact factor: 3.452

Review 3.  Transthoracic vs transhiatal surgery for cancer of the esophagogastric junction: a meta-analysis.

Authors:  Ming-Tian Wei; Yuan-Chuan Zhang; Xiang-Bing Deng; Ting-Han Yang; Ya-Zhou He; Zi-Qiang Wang
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

4.  Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients.

Authors:  J Rüdiger Siewert; M Feith; M Werner; H J Stein
Journal:  Ann Surg       Date:  2000-09       Impact factor: 12.969

5.  Long-term outcomes of extended proximal gastrectomy for oesophagogastric junctional tumours.

Authors:  Omar Khan; Steven Goh; Ben Byrne; Shaw Somers; Stuart Mercer; Simon Toh
Journal:  World J Surg       Date:  2011-10       Impact factor: 3.352

6.  Adenocarcinoma of gastric cardia in the elderly: surgical problems and prognostic factors.

Authors:  Natale Di Martino; Giuseppe Izzo; Angelo Cosenza; Guido Cerullo; Francesco Torelli; Antonio Brillantino; Alberto del Genio
Journal:  World J Gastroenterol       Date:  2005-09-07       Impact factor: 5.742

7.  Comparison of Efficacy Between Transabdominal and Transthoracic Surgical Approaches for Siewert Type II Adenocarcinoma of the Esophagogastric Junction: A Systematic Review and Meta-Analysis.

Authors:  Zonglin Li; Huaiwu Jiang; Jin Chen; Yifan Jiang; Yi Liu; Linxia Xu
Journal:  Front Oncol       Date:  2022-04-29       Impact factor: 5.738

8.  Transthoracic versus abdominal-transhiatal resection for treating Siewert type II/III adenocarcinoma of the esophagogastric junction: a meta-analysis.

Authors:  Zhi Zheng; Jun Cai; Jie Yin; Jun Zhang; Zhong-Tao Zhang; Kang-Li Wang
Journal:  Int J Clin Exp Med       Date:  2015-10-15

9.  Characteristics of gastric cancer with esophageal invasion and aspects of surgical treatment.

Authors:  Kohei Wakatsuki; Tomoyoshi Takayama; Masato Ueno; Sohei Matsumoto; Koji Enomoto; Tetsuya Tanaka; Yoshiyuki Nakajima
Journal:  World J Surg       Date:  2009-07       Impact factor: 3.352

10.  The pattern of recurrence of adenocarcinoma of the oesophago-gastric junction.

Authors:  J Wayman; M K Bennett; S A Raimes; S M Griffin
Journal:  Br J Cancer       Date:  2002-04-22       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.